These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46 related articles for article (PubMed ID: 14524595)
1. Role of MTHFR 677C>T and 1298A>C gene polymorphisms on renal toxicity caused by lead exposure in wastewater treatment plant workers. Saad-Hussein A; Shousha WG; Al-Sadek SYM; Ramadan SS Environ Sci Pollut Res Int; 2023 Jul; 30(35):84758-84764. PubMed ID: 37369904 [TBL] [Abstract][Full Text] [Related]
2. Relationship of MTHFR gene polymorphisms with renal and cardiac disease. Trovato FM; Catalano D; Ragusa A; Martines GF; Pirri C; Buccheri MA; Di Nora C; Trovato GM World J Nephrol; 2015 Feb; 4(1):127-37. PubMed ID: 25664255 [TBL] [Abstract][Full Text] [Related]
3. Clinical use and rational management of homocysteine, folic acid, and B vitamins in cardiovascular and thrombotic diseases. Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M Z Kardiol; 2004 Jun; 93(6):439-53. PubMed ID: 15252738 [TBL] [Abstract][Full Text] [Related]
4. DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations. Stanger O; Herrmann W; Pietrzik K; Fowler B; Geisel J; Dierkes J; Weger M; Clin Chem Lab Med; 2003 Nov; 41(11):1392-403. PubMed ID: 14656016 [TBL] [Abstract][Full Text] [Related]
5. Hyperhomocysteinemia in patients with heart failure referred for cardiac transplantation: preliminary observations. Schofield RS; Wessel TR; Walker TC; Cleeton TS; Hill JA; Aranda JM Clin Cardiol; 2003 Sep; 26(9):407-10. PubMed ID: 14524595 [TBL] [Abstract][Full Text] [Related]
6. Treatment of hyperhomocysteinemia in pediatric heart transplant recipients. Parisi F; Danesi H; Di Ciommo V; Fina F; Giannone G; Colistro F; Di Donato RM; Catena G J Heart Lung Transplant; 2003 Jul; 22(7):778-83. PubMed ID: 12873546 [TBL] [Abstract][Full Text] [Related]
8. Effect of immunosuppressive therapy, serum creatinine, and time after transplant on plasma total homocysteine in patients following heart transplantation. Cook RC; Tupper JK; Parker S; Kingsbury K; Frohlich JJ; Abel JG; Gao M; Ignaszewski AP J Heart Lung Transplant; 1999 May; 18(5):420-4. PubMed ID: 10363685 [TBL] [Abstract][Full Text] [Related]
9. Plasma homocysteine levels in renal transplanted patients on cyclosporine or tacrolimus therapy: effect of treatment with folic acid. Fernández-Miranda C; Gómez P; Díaz-Rubio P; Estenoz J; Carillo JL; Andrés A; Morales JM Clin Transplant; 2000 Apr; 14(2):110-4. PubMed ID: 10770414 [TBL] [Abstract][Full Text] [Related]
10. Effective treatment of hyperhomocysteinemia in heart transplant recipients with and without renal failure. Cook RC; Parker S; Kingsbury K; Frohlich JJ; Abel JG; Gao M; Ignaszewski AP J Heart Lung Transplant; 2001 Mar; 20(3):310-5. PubMed ID: 11257557 [TBL] [Abstract][Full Text] [Related]
11. Interplay between methylenetetrahydrofolate reductase gene polymorphism 677C-->T and serum folate levels in determining hyperhomocysteinemia in heart transplant recipients. Potena L; Grigioni F; Viggiani M; Magnani G; Sorbello S; Falchetti E; Sassi S; Mantovani V; Bacchi-Reggiani L; Magelli C; Branzi A J Heart Lung Transplant; 2001 Dec; 20(12):1245-51. PubMed ID: 11744407 [TBL] [Abstract][Full Text] [Related]
12. Chronic heart failure and micronutrients. Witte KK; Clark AL; Cleland JG J Am Coll Cardiol; 2001 Jun; 37(7):1765-74. PubMed ID: 11401109 [TBL] [Abstract][Full Text] [Related]